Leveraging AI technologies in clinical care: the use of collaborative intelligence

Collaborative intelligence to transform healthcare services digitally.

MindMed’s Phase 2b Compound MM-120 Shows Promise In Treating Generalized Anxiety Disorder

Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), a clinical-stage biopharmaceutical company dedicated to pioneering innovative treatments for brain health disorders, has announced topline outcomes

December 14, 2023

Pharmalittle: Novo Nordisk spent $11 million on doctors to promote Ozempic and similar drugs; China offers foreign drugmakers an olive branch

Good morning, everyone, and nice to see you again after an extended holiday break, at least for many on this side of the pond. We

July 5, 2023

Biden awards $24M to develop mRNA tech targeting cancer, other diseases

The Biden administration’s new biomedical research agency is launching a $24.8 million project to develop mRNA platforms with the goal of using the technology to

August 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.